PARP1 and ovarian carcinoma: The poly(adenosine diphosphate ribose) polymerase (PARP) family of DNA end-binding nuclear proteins is involved in one such pathway of DNA repair [3] and inhibition of PARP1 (PARPi) has become a promising therapeutic approach for the treatment of certain types of cancers, especially breast and ovarian cancer.